The rate of uptake of cardiac glycosides into human cultured cells and the effects of chloroquine on it.
HeLa cells grown on Petri dishes were either pulse labelled with various cardiac glycosides or grown in low concentrations of them for up to 2 days; either in the presence of chloroquine or not. The cells were then homogenised and the cell free homogenate layered on a continuous sucrose gradient; and the glycoside content and that of various markers measured. In another series of experiments HeLa cells were grown on plastic beads under the above conditions and then the content of glycosides and of some marker enzymes measured. The rate of internalisation of ouabain, digoxin and digitoxin from the plasma membrane preparation produced by the bead method is at 9% hr-1, similar to the rate of loss of digoxin and digitoxin from whole cells but much faster than that of ouabain. In the sucrose gradient experiments it was found that [3H]ouabain, digoxin and digitoxin all initially co-distribute with the plasma membrane marker, 5'-nucleotidase, and then leave this fraction of the homogenate at a fast rate when kept at 37 degrees, to co-distribute with the lysosomal marker, beta-hexosaminidase. At 2 degrees the ouabain remains co-distributed with the plasma membrane marker. The rate of transfer is estimated to be some 90% hr-1, much faster than previously thought. Chloroquine causes an increased retention of digoxin and digitoxin in the lysosomal fraction of the homogenate. These results are best explained by supposing that the sodium pump-glycoside complex rapidly enters a region of the peripheral cytoplasm, and that this region then controls the subsequent exit of digoxin and digitoxin from the cell. The main barrier for ouabain occurs at a stage later than this. The consequences of this model on other aspects of pump activity is discussed.
D002301:Cardiac Glycosides / Q000378:metabolism*; D002460:Cell Line; D002738:Chloroquine / Q000494:pharmacology*; D004077:Digoxin / Q000378:metabolism; D006367:HeLa Cells / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D010042:Ouabain / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D013696:Temperature; D013997:Time Factors; D001619:beta-N-Acetylhexosaminidases / Q000378:metabolism
D002301:Cardiac Glycosides; D010743:Phospholipids; D010042:Ouabain; D004077:Digoxin; D002738:Chloroquine; D007770:L-Lactate Dehydrogenase; D001619:beta-N-Acetylhexosaminidases